Non-diuretic-based antihypertensive therapy and potassium homeostasis in elderly patients

Coronary Artery Disease

Volumn 8, Issue 8-9, 1997, Pages 499-504

  Weir, Matthew R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Elderly; Hyperkalemia; Hypertension; Potassium; Renal function

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT;

AGING; ANTIHYPERTENSIVE THERAPY; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; PRIORITY JOURNAL; REVIEW;

AGED; AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; CALCIUM CHANNEL BLOCKERS; DIURETICS; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FUNCTION TESTS; MALE; POTASSIUM; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0030723075     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Frocht A. Fillit H: Renal disease in the geriatric patient. J Am Geriatr Soc 1984, 32:28-43.
2. Meyer BR: Renal function in aging. J Am Geriatr Soc 1989, 37:791-800.
3. Schmieder RE, Schachinger H, Messerli FH: Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension 1994, 23:351-357.
4. Lindeman RD, Tobin JD, Shock NW: Hypertension and the kidney. Nephron 1987, 47 (suppl 1):62-67. A significance decline in renal function correlates independently with age and mean arterial pressure.
5. Rosansky SJ, Hoover DR, King L, Gibson J: The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 1990, 150:2073-2076.
6. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. The MRFIT Research Group. JAMA 1992, 268:3085-3091.
7. Tierney WM, Harris LE, Copley JB, Luft FC: Effect of hypertension and type II diabetes on renal function in an urban population. Am J Hypertens 1990, 3:69-75.
8. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP: Renal insufficiency in treated essential hypertension. N Engl J Med 1989, 320:684-688. Patients with hypertension treated with traditional agents developed renal dysfunction. Hypertensives of African-American descent were twice as likely as while patients to display elevations in serum creatinine (23 versus 11%).
9. Friedman JR, Norman DC, Yoshikawa TT: Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. J Am Geriatr Soc 1989, 37:145-149. Despite the fact that aging and hypertension are recognized as risk factors for declining kidney function, this problem commonly escapes diagnosis in the elderly.
10. Weir MR: Salt intake and hypertensive renal injury in African-Americans: a therapeutic perspective. Am J Hypertens 1995, 8:635-644.
11. Bakris GL, Weir MR, Sowers JR: Therapeutic challenges in the obese diabetic patient with hypertension. Am J Med 1996, 101 (suppl 3A): 33S-46S. Hypertensive diabetics need careful management of blood pressure in order to avoid target-organ damage. Specific efforts should be made to avoid medications that lead to a decrease in carbohydrate tolerance, to abnormalities in lipids and to abnormalities of potassium homeostasis.
12. Sterns RH, Cox M, Feig PU, Singer I: Internal potassium balance and the control of the plasma potassium concentration. Medicine 1981. 60:339-354
13. Young DB, Paulsen AW: Interrelated effects of aldosterone and plasma potassium on potassium excretion. Am J Physiol 1983, 244:F28-F35.
14. Young DB: Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 1988, 255:F811-F816.
15. Houston MC: Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med 1991, 90 (suppl 5A):42s-47s. NSAIDs attenuate the antihypertensive properties of most commonly used drugs through renal salt and water retention and by reducing vasodilation. Hyperkalemia is also a common observation.
16. Stillman MT, Schlesinger PA: Nonsteroidal anti-inflammatory drug nephrotoxicity. Should we be concerned? Arch Intern Med 1990, 150:268-270.
17. Lee JB: Prostaglandins and the renal antihypertensive and natriuretic endocrine function. Recent Prog Horm Res 1974, 30:481-532.